May 7th 2024
An analysis showed an association between patients who previously had undergone intravitreal injections and cataract surgery and a higher risk of the development of a non-clearing vitreous hemorrhage, retinal detachment, retinal tear, and glaucoma surgery.
Heading to ARVO? You’re invited to dinner COPE CE/CME. Or join virtually!
May 6 & 7, 2024
Register Now!
(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
May 18-19, 2024
Register Now!
(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications
View More
(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference
View More
(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
17th Annual Controversies in Modern Eye Care
View More
Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
What’s New in MGD Beyond Heating and Squeezing?
View More
The Ins and Outs of Lubricating Eye Drops
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Expert Perspectives in Diabetic Macular Edema – Considering Pathogenesis & Inflammation in Treatment Selection
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (CME Credit)
View More
Community Practice Connections™: Novel Treatment Strategies in the Management of nAMD & DME - Lessons from Clinical Trial and Real-World Data
View More
Medical Crossfire®: Expert Insights in Anti-VEGF Dosing for nAMD and DME – Optimizing Reduction in Treatment Burden
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (COPE Credit)
View More
EyeCon 2024
September 27-28, 2024
Register Now!
Heading to AAO? You’re invited to a CME dinner. Or join virtually!
Date TBA
Register Now!
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
Secrets of the glaucoma surgeon: preventing complications
June 5th 2004The use of antiproliferative agents has helped increase thelikelihood of successful filtering surgery by inhibiting the wound healingresponse. The problem is that these agents also contribute to the risk ofbleb leak and bleb-associated infection, reported Paul J. Lama, MD, of theUniversity of Medicine and Dentistry of New Jersey, Newark, and the Veterans'Administration Medical Center, East Orange, NJ.
Read More
Peripheral iris fixation technique yields promising results
June 1st 2004Baltimore-Peripheral iris fixation of a foldable posterior chamber IOL using a modified McCannel suture appears to be a useful technique for the management of delayed-onset within-the-bag IOL subluxation in eyes with pseudoexfoliation syndrome, said Aruoriwo M. Oboh-Weilke, MD
Read More
Study: modulator in wound healing with trabeculectomy
May 1st 2004Dorado, Puerto Rico-After positive results from a European clinical trial showed transforming growth factor-b2 (TGF-b2) mono clonal antibody was effective in delaying wound healing after first-time trabeculectomy, U.S. investigators are undertaking a multicenter clinical trial to compare the new agent with 5-fluorouracil (5-FU), reported Marshall N. Cyrlin, MD.
Read More
Lens aims to increase range of accommodation
May 1st 2004San Francisco-Clinical trials are under way in centers in Germany and Colombia to evaluate a dual-optic accommodating IOL (Synchrony, Visiogen) designed to offer amplified, consistent accommodation across a wide range of IOL powers, said Stephen D. McLeod, MD.
Read More
Refractive Lens Exchange holds promise as option to LASIK
May 1st 2004Dorado, Puerto Rico - Refractive lens exchange (RLE) does look promising as a viable option to corneal refractive procedures, particularly in those patients with high myopia or hyperopia. However, surgeons need to review the advantages and limitations of the intraocular procedure carefully with patients, according to Terrence P. O'Brien, MD.
Read More
Bleb leaks becoming more common with antimetabolite use
April 15th 2004Madison, WI-Leaking blebs occur fairly often now that antimetabolites are used in glaucoma surgery. A variety of treatment approaches can be used to manage them, and the outcomes are usually successful if care is taken in the management process, according to Todd Perkins, MD.
Read More
ICLs gain acceptance with proven tolerability
April 15th 2004Mendoza, Argentina-Intraocular contact lenses (ICLs) (STAAR Surgical) have been used for many years outside the United States, and the results indicate that the ICLs can be tolerated over the long term. More patients have been opting to have this type of lens implanted following a previous LASIK procedure, and their visual outcomes have been good, according to Roberto Zaldivar, MD.
Read More
Phakic IOL addresses high levels of refractive errors
April 15th 2004Carlsbad, CA-The Vision Membrane multifocal IOL (Vision Membrane Technologies Inc.) is a silicone anterior chamber phakic IOL that is intended to treat patients with myopia, hyperopia, and presbyopia. The IOL is extremely thin, even for cases of extreme myopia, and can eliminate the glare and halos normally associated with corneal refractive procedures.
Read More
ARVO 2004 Glaucoma presentations
April 1st 2004At this year's ARVO meeting, glaucoma specialists can broaden their clinicalknowledge of topics ranging from surgery and wound healing to neuroprotectionto retinal nerve fiber layer imaging. Members of Ophthalmology Times'Editorial Advisory Board reviewed dozens of glaucoma abstracts to be presentedat the meeting. Some of the board's selections are highlighted here.
Read More
Investigational implant provides for aqueous outflow
March 15th 2004Anaheim, CA-Performing cataract surgery in an eye with a failing filtering bleb is a tricky business, which has been addressed by a few different procedures. Successful intervention can be achieved in carefully selected patients. However, in those in which intervention might be problematic, a new investigational device is under study to lower IOP, according to Reay H. Brown, MD.
Read More
ALT still gold standard for initial glaucoma treatment
March 15th 2004Anaheim, CA-Selective laser trabeculoplasty (SLT) seems to be as effective for treating patients who had undergone argon laser trabeculoplasty (ALT) as the initial treatment for glaucoma, and may be more effective for re-treatments, but data and fol- low-up are limited, said Douglas N. Johnson, MD, at the annual meeting of the American Academy of Ophthalmology.
Read More
Liquefaction device assures safe, gentle lens removal
March 1st 2004New Orleans-The AquaLase liquefaction device (Alcon) is a new technology for lens removal that provides the advantages of excellent safety for the cornea and posterior capsule without sacrificing efficiency, said Stephen F. Brint, MD.
Read More
Risk of retinal detachment after myopic RLE examined
March 1st 2004Anaheim, CA-Myopic patients considering refractive lens exchange (RLE) for correcting their myopic refractive errors should be aware of the risk of retinal detachment (RD) and the retinal re-attachment rate and outcomes, said Barry S. Seibel, MD.
Read More
Corneal implant applications expand to include keratoconus
February 15th 2004Washington, DC-Micro-thin prescription inserts (Intacs, Addition Technology), which received FDA approval in the United States in 1999 for the treatment of mild myopia, are an alternative to tissue-ablating laser vision procedures and have a number of advantages.
Read More